Texto: 
renal chromophobe carcinoma eosinophile type that perforates renal capsule and infiltrates perirenal fat tissue
treated with left radical nephrectomy
• scout abdominal scan from a comuter tomography  demonstrates a radio-opaque lobular mass  projected in the left renal fossa. 

• mdct shows a heterogeneous mass arising from the left kidney
• there is irregular enhancement after iv contrast
chromophobe renal cell carcinoma, eosinophile type, that perforates renal capsule and infiltrates perirenal fat tissue
• renal cell carcinoma
* oncocytoma
• transitional cell carcinoma
40 y.o. woman with evolution over one month or lower urinary tract symptoms, left renal pain, hematuria, and no improvement with treatment.
renal cell carcinoma:
incidence 80-90% of all renal malignant primaries in adults.
arises from proximal tubular cells; 30% found incidentally with imaging.
tumor growth pattern: papillary (best prognosis); trabecular/tubular/cystic/solid (poorer prognosis). predisposing factors: tobacco, von hippel-lindau disease, hemodialysis, acquired cystic disease of uremia.
the most common sites of metastases are the lung (55%), lymph nodes, liver, bone, adrenals, contralateral kidney, brain, heart, spleen. it?s important to know that 28% of patients have clinically apparent multiple distant metastases at presentation! 
radiology findings in ct: mostly hterogeneous enhancement (due to cystic areas or necrosis), subcapsular/perinephric hemorrhage. mri best modality to assess stage iii+iv disease: low to medium signal intensity on t1wi; hyperintense areas are usually due to hemorrhage. heterogeneous signal intensity on t2wi.
staging:
    i: confined to within renal capsule
   ii: extension into perinephric fat but confined to gerota fascia
  iiia: extension into renal vein or ivc
 iiib: positive lymph nodes
 iiic: extension into renal vein + lymph nodes
 iva: extensio into adjacent organs( other than ipsilateral adrenal)
 ivb: distant metastases

treatment and prognosis: recurrence in 11% after 10 years. radical nephrectomy has a 2-5% operative mortality. tumor stage and histological grade are the most important prognosticators!

chromophobe carcinoma of kidney:

a distinct type of renal cell carcinoma
5% all
males= females in contradistinction to classic rcc where male 2-3:1 females
unlike other renal cell carcinomas can be hypovascular on imaging
birt-hogg-dube syndrome a risk factor for chromophobe renal cell carcinoma and these patients need to be screened
can look identical to oncocytoma, and in case reports has coexisted with this.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term=renal+chromophobe+carcinoma&tool=querysuggestion


Keywords by value: 
- renal: 0.08654411964465401
- chromophobe: 0.07924061504688988
- carcinoma: 0.04354027271938637
- :: 0.04063909450752953
- eosinophile: 0.03962030752344494
- cell: 0.03630940445184361
- perforates: 0.03468272420358826
- %: 0.031355611760498996
- capsule: 0.03118559785577577
- perirenal: 0.028843250117609565
- prognosis: 0.027325917904508373
- nodes: 0.02602039123392295
- !: 0.025727981890373855
- oncocytoma: 0.02497717701548322
- metastases: 0.02461167943849203
- radical: 0.02404396638726639
- infiltrates: 0.02390566679775289
- lymph: 0.023255342082772898
- confined: 0.023154861922862258
- distant: 0.022412930460572602
- nephrectomy: 0.021776298923210684
- females: 0.021371125453573392
- extension: 0.020564004412460587
- kidney: 0.02029471992168546
- &: 0.020234075677357966
- comuter: 0.01981015376172247
- trabecular/tubular/cystic/solid: 0.01981015376172247
- hterogeneous: 0.01981015376172247
- subcapsular/perinephric: 0.01981015376172247
- iii+iv: 0.01981015376172247
- extensio: 0.01981015376172247
- prognosticators: 0.01981015376172247
- males=: 0.01981015376172247
- 2-3:1: 0.01981015376172247
- birt-hogg-dube: 0.01981015376172247
- coexisted: 0.01981015376172247
- term=renal+chromophobe+carcinoma: 0.01981015376172247
- type: 0.01941993861806906
- into: 0.018277090947952424
- tool=querysuggestion: 0.018252519648104613
- •: 0.01760690282692009
- fat: 0.017520757232909887
- radio-opaque: 0.01734136210179413
- iiic: 0.01734136210179413
- important: 0.017252964860880557
- projected: 0.01669488553448676
- stage: 0.016382177208666727
- primaries: 0.0161934393517582
- poorer: 0.0161934393517582
- uremia: 0.0161934393517582
- adrenals: 0.0161934393517582
- iiia: 0.0161934393517582
- iva: 0.0161934393517582
- ivb: 0.0161934393517582
- cmd=search: 0.0161934393517582
- best: 0.0161580341523064
- contradistinction: 0.015783727988176278
- mdct: 0.015437321966092552
- hypovascular: 0.015437321966092552
- iiib: 0.015137251420868905
- screened: 0.015137251420868905
- //www.ncbi.nlm.nih.gov/entrez/query.fcgi: 0.015137251420868905
- ?: 0.014988222474716885
- gerota: 0.014872570441865796
- 80-90: 0.014635805238140344
- 2-5: 0.014635805238140344
- hemodialysis: 0.014226093874558423
- heterogeneous: 0.014122225423797779
- vein: 0.0138963295371421
- intensity: 0.013881665961255287
- db=pubmed: 0.013879687852474697
- medium: 0.013724647691829862
- ;: 0.013654524865972541
- predisposing: 0.01357961730725105
- identical: 0.013193436954606874
- hippel-lindau: 0.013078171124522489
- evolution: 0.012968530306164214
- rcc: 0.012968530306164214
- areas: 0.012922908634813785
- hemorrhage: 0.01278317565921814
- know: 0.012764099343904156
- fascia: 0.012764099343904156
- carcinomas: 0.012322053738856842
- scout: 0.012167013578212007
- perinephric: 0.012167013578212007
- von: 0.012093328583104163
- unlike: 0.012093328583104163
- histological: 0.011952833398876445
- t1wi: 0.011820607556128281
- transitional: 0.011757302214630087
- tobacco: 0.011577430961431129
- arises: 0.011520537010904634
- t2wi: 0.011520537010904634
- distinct: 0.01141089619254636
- mostly: 0.011206465230286301
- cystic: 0.011077000931468578
- staging: 0.011064490170462633
- ipsilateral: 0.011064490170462633
- organs: 0.011019090828176073
- ,: 0.010950070065867804
- all: 0.010862577480590071
- lobular: 0.010846144668319605
- *: 0.010685562726786696
- look: 0.010685562726786696
- contralateral: 0.010609379464594153
- modality: 0.010535694469486307
- sites: 0.01046434908001534
- mortality: 0.01046434908001534
- operative: 0.010361406302416928
- spleen: 0.01032811397480987
- acquired: 0.010295307683975819
- enhancement: 0.010294331533137241
- tomography: 0.010262973442510426
- due: 0.010248436642484673
- ivc: 0.010231097858258839
- signal: 0.010126176765270917
- that: 0.009950431877924652
- patients: 0.009939661120746185
- +: 0.009907413880229764
- adults: 0.009800384556658406
- factor: 0.009800384556658406
- papillary: 0.009748722717951217
- adrenal: 0.009723330458953615
- assess: 0.009624536923175825
- to: 0.009597036144786207
- need: 0.009576722544642603
- disease: 0.009416208143027219
- 55: 0.009309414807875487
- hematuria: 0.009108639301502791
- tissue: 0.00910301657731503
- 28: 0.009051745350976298
- imaging: 0.008998084604294845
- improvement: 0.008960010531829658
- tumor: 0.008953853040947467
- tubular: 0.008942104532618024
- urinary: 0.008889227010347923
- most: 0.00886667479428349
- other: 0.00885230808405595
- incidence: 0.008803772188799072
- 11: 0.008787064371973189
- can: 0.008711111696490201
- incidentally: 0.008705339328892572
- factors: 0.008626482430440278
- left: 0.008594204667621706
- from: 0.008537768852725027
- tract: 0.008505798882188905
- apparent: 0.00849115914955701
- clinically: 0.008419357801677005
- recurrence: 0.00837735300839127
- growth: 0.00834977976661191
- ii: 0.00828229148099646
- (: 0.008116423890380454
- radiology: 0.008115756712111693
- 40: 0.0080790170761532
- ): 0.008017277439475338
- hyperintense: 0.007972270258209372
- arising: 0.007949221943226925
- after: 0.007946072820715517
- i: 0.00793778583197418
- are: 0.007853082286716417
- where: 0.007837398326240265
- fossa: 0.007826516024047481
- treatment: 0.0077735593689927515
- reports: 0.007741304260311991
- cells: 0.007699880211573028
- irregular: 0.007659205960688494
- necrosis: 0.007580001603246528
- 30: 0.007384470419000169
- classic: 0.007357876132152972
- pattern: 0.007340319863081525
- grade: 0.007314239984159484
- http: 0.00727143505164107
- has: 0.007212134698850688
- iv: 0.0070076964886766156
- risk: 0.006955520555863117
- malignant: 0.006940832980627643
- or: 0.006751838757058703
- heart: 0.006672089098671403
- liver: 0.006620722496253312
- presentation: 0.006614383448294568
- 10: 0.006473312872689686
- positive: 0.006231203573672173
- adjacent: 0.006071542121650039
- found: 0.006051742953824972
- be: 0.005922502127388446
- usually: 0.005831299446891594
- brain: 0.005778318029893848
- proximal: 0.005765265576869697
- month: 0.00576093155236092
- treated: 0.005747979406930021
- in: 0.00568176040638546
- years: 0.005638748622513444
- 5: 0.0056183380279644125
- lung: 0.005562155326379205
- y.o: 0.005542425691206068
- s: 0.005507343072167612
- syndrome: 0.0054919248915385206
- scan: 0.0053758909223213
- a: 0.0053474130582283315
- mass: 0.005341397784033999
- low: 0.005339703489587415
- shows: 0.005279491460064897
- one: 0.0052038907490126836
- than: 0.005031570460490503
- common: 0.005025319577430107
- these: 0.0049974038021524505
- over: 0.004889084472224635
- on: 0.0048801641283062564
- abdominal: 0.004799818512633967
- symptoms: 0.004785747139096942
- bone: 0.004771763329123303
- woman: 0.004435736960649228
- mri: 0.004411855853740719
- lower: 0.004318791167109804
- it: 0.004316513223669701
- contrast: 0.004298372329905406
- case: 0.004201133557005103
- demonstrates: 0.004194654385737497
- have: 0.004158287816550768
- but: 0.004095513036030422
- findings: 0.004087274013011145
- multiple: 0.004044507872987121
- within: 0.0036632166480586106
- male: 0.003472371995252749
- there: 0.0028577877673370534
- and: 0.00283160233736074
- ct: 0.0026860756256000965
- at: 0.002601714950183445
- pain: 0.002345186893327494
- this: 0.0021598589063238946
- no: 0.0019335823611321395
- for: 0.001638445277848798
- of: 0.0015708377635683833
- the: 0.0015533627494789416
- with: 0.0013146536639313453
- is: 0.001263574782887024
- .: 0.0011168393378940401
